Role of F-dopa PET/CT imaging in the management of patients with In-pentetreotide negative GEP tumours

Nuclear Medicine Communications

Volumn 28, Issue 6, 2007, Pages 473-477

  Ambrosini, Valentina ^a   Tomassetti, Paola ^a   Rubello, Domenico ^a   Campana, Davide ^a   Nanni, Cristina ^a   Castellucci, Paolo ^a   Farsad, Mohsen ^a   Montini, Giancarlo ^a   Al Nahhas, Adil ^b   Franchi, Roberto ^b   Fanti, Stefano ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Conventional radiological imaging; GEP endocrine tumours

Indexed keywords

FLUORODIHYDROXYPHENYLALANINE F 18; PENTETATE INDIUM IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOPSY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; SCINTIGRAPHY; TUMOR VOLUME; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; DIGESTIVE SYSTEM NEOPLASMS; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 34247594315     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328182d606     Document Type: Article

References (20)

1. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128:1717-1751.
2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97:934-959.
3. Lepage C, Bouvier AM, Phelip JM, Hatem C, Vernet C, Faivre J. Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut 2004; 53:549-553.
4. Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology 2004; 80(suppl 1):3-7.
5. Vinik A. Neoplasms of gastroenteropancreatic endocrine system. In: Holland J, Frei EI, Bast RJ, Kufe D, Morton D, Weichselbaum R (editors). Cancer Medicine. Philadelphia: American Cancer Society; 1993 pp. 1180-1209.
6. Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, et al. UKNETwork for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54(suppl 4):iv1-16.
7. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005; 104:2292-2309.
8. Lemmer K, Ahnert-Hilger G, Hopfner M, Hoegerle S, Faiss S, Grabowski P, et al. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells. Life Sci 2002; 71:667-678.
9. Becherer A, Szabo M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, et al. Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. J Nucl Med 2004; 45:1161-1167.
10. Rubello D, Rufini V, De Carlo E, Martini C, Calcagni ML, Sicolo N, et al. New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues. Minerva Endocrinol 2003; 28:259-296.
11. 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001; 220:373-380.
12. 18F-DOPA whole body PET-initial results. Radiology 2002; 222:507-512.
13. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003; 30:689-694.
14. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001; 28:64-71.
15. 18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 2003; 88:637-641.
16. 18F]FDG in the imaging of small cell lung carcinoma: preliminary results. Eur J Nucl Med Mol Imaging 2003; 30:1266-1269.
17. 18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid. J Nucl Med 2005; 46:1240-1243.
18. Gore RM, Berlin JW, Mehta UK, Newmark GM, Yaghmai V. GI carcinoid tumours: appearance of the primary and detecting metastases. Best Pract Res Clin Endocrinol Metab 2005; 19:245-263.
19. Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, et al. Staging of carcinoid tumours with (18)F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 2006; 7:728-734.
20. 18F-DOPA injection for PET of carcinoid tumor. J Nucl Med 2006; 47:1732-1735.